A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2006
12/05/2006	US7144987 Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders
12/05/2006	US7144918 Enzyme inhibitors; anticancer agents
12/05/2006	US7144915 Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144873 Therapy for anticancer agents, blood disorders; dissolving in nonaqueous solvent
12/05/2006	US7144586 Compositions for preventing hormone induced adverse effects
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
12/05/2006	CA2387531C Purine derivatives
12/05/2006	CA2384929C A novel angiogenesis inhibitor
11/2006
11/30/2006	WO2006128184A2 Pyrimidine or triazine fused bicyclic metalloprotease inhibitors
11/30/2006	WO2006128142A2 Inhibitors of cytosolic phospholipase a2
11/30/2006	WO2006127642A2 Use of botulinum toxin for treating peritoneal adhesions
11/30/2006	WO2006127249A1 Method and composition for treating osteoarthritis
11/30/2006	WO2006126948A1 Piperidines for the treatment of chemokine mediated diseases
11/30/2006	WO2006126947A1 Piperidines for the treatment of chemokine mediated diseases
11/30/2006	WO2006126514A1 Arylacetate derivative having isoxazole skeleton
11/30/2006	WO2006126505A1 Stat function inhibitor and application thereof
11/30/2006	WO2006125651A2 Ligustilide derivatives for the treatment of inflammatory disorders
11/30/2006	US20060270719 2-[(Cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-2-yl-benzyl)-amino]-N-hydroxy-acetamide; selective inhibitors of matrix-degrading metalloproteinases, especially MT1-MMP, MMP-2 and MMP-9; Osteoporosis; Antitumor, antiproliferative agents
11/30/2006	US20060270689 Novel Fused Heterocycles and Uses Thereof
11/30/2006	US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006	US20060270681 Pyridazine derivatives
11/30/2006	US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/30/2006	US20060270676 Hydrazono-malonitriles
11/30/2006	US20060270660 Processes for preparing substituted pyrimidines
11/30/2006	US20060270644 Nitrate esters of corticoid compounds and pharmaceutical applications thereof
11/30/2006	US20060269627 Isolation of a Dual Cox-2 and 5-Lipoxygenase Inhibitor from Acacia
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	DE69735603T2 PTHrP Analogen PTHrP analogs
11/30/2006	DE202006014985U1 Composition, useful for improving skin- and bone condition, comprises fat oils from seeds of black nettle (Perilla frutescens), vitamin C, vitamin E, calcium, vitamin K1 and vitamin D3
11/30/2006	CA2613434A1 Method and composition for treating osteoarthritis
11/30/2006	CA2607857A1 Inhibitors of cytosolic phospholipase a2
11/29/2006	EP1726584A1 2-aminoquinazoline derivative
11/29/2006	EP1726582A2 Compounds and methods for the inhibition of the expression of vcam-1
11/29/2006	EP1725261A2 Use for interleukin-33 (il-33) and the il-33 receptor complex
11/29/2006	EP1725226A2 The treatment of inflammatory disorders and pain using beta-aminoalcohols
11/29/2006	EP1497656B1 Diagnosis of carcinoma using raig1 polypeptides
11/29/2006	EP1313504B1 Methods and compositions for inhibiting angiogenesis
11/29/2006	EP1248804B1 Recombinant antibodies to human interleukin-1 beta
11/29/2006	EP1248604B1 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
11/29/2006	EP1239886B1 Labelled ascorbic acid derivatives
11/29/2006	EP1043995B1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
11/29/2006	CN1871343A Method and system for preparing stem cells from fat tissue
11/29/2006	CN1871024A Remedy and therapeutic method for periodontal diseases and pulpal diseases
11/29/2006	CN1871012A 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
11/29/2006	CN1871000A Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain
11/29/2006	CN1869208A Preparation of caterpillar fungus SOD and health-care product containing caterpillar fungus SOD
11/29/2006	CN1868537A Therapeutic effect of type II collagen allosteric peptide for treating rheumatoid arthritis
11/29/2006	CN1868535A Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method
11/29/2006	CN1868522A Medicine composition, its prepn. method, and quality control method
11/29/2006	CN1868521A Traditional Chinese medicine tablet for treating medical arthralgia-syndrome and its prepn. method
11/29/2006	CN1868517A Pure traditional Chinese medicine for radical curing of rheumatoid disease at base of of cause disease
11/29/2006	CN1868516A Medicine for treating fracture and injury
11/29/2006	CN1868515A Traditional Chinese medicine for treating rheumatism
11/29/2006	CN1868512A Traditional Chinese medicine soft capsule for treating rheumatism and ostalgia, and its prepn. method
11/29/2006	CN1868510A Plaster for treating traumatic injuries and rheumatism, and its prepn. method
11/29/2006	CN1868509A External use medicine for treating rheumatic arthritis, and its prepn. method
11/29/2006	CN1868502A Medicine composition used for treating rheumatoid arthritis, and its prepn. method
11/29/2006	CN1868491A Medicine for radical cure of rheumatic arthritis and rheumatoid arthritis
11/29/2006	CN1868487A Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn.
11/29/2006	CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/29/2006	CN1286822C Pyrimidinone compounds
11/29/2006	CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006	CN1286530C Self-regulated apoptosis of inflammatory cells by gene therapy
11/29/2006	CN1286520C Pharmaceutical composition for treating hyperosteogeny and intervertebral disc protrusion
11/29/2006	CN1286512C Impediment pain tonic wine
11/29/2006	CN1286502C Medicine for treating gout affection and its symptoms
11/29/2006	CN1286500C Medication for treating joint pain
11/29/2006	CN1286495C Medicine for treating rheumatoid arthritis and ankylosing spondylitis and its preparation method
11/29/2006	CN1286494C Ointment for treating fracture and injury
11/29/2006	CN1286492C Traditional Chinese medicinal plaster
11/29/2006	CN1286486C Chinese medicine for treating traumatic injury and its preparing method
11/29/2006	CN1286482C Bone joining pill
11/29/2006	CN1286474C Medicine for treating bone wound
11/29/2006	CN1286466C Chinese medicine sapogenin w3 for treating rheumatism and preparation and use
11/28/2006	US7141648 Synthesis of cyclosporin analogs
11/28/2006	US7141590 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
11/28/2006	US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006	US7141553 A3AR agonists for the treatment of inflammatory arthritis
11/28/2006	US7141547 Albumin fusion proteins comprising GLP-1 polypeptides
11/28/2006	US7141545 Osteoarthritis, and trauma-related cartilage injuries using insulin-like growth factor I (IGF-I) is provided. The method comprises increasing the amount of IGF-I at the diseased or injured articular site to a therapeutically effective level
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	US7141262 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents
11/28/2006	CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/28/2006	CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006	CA2301185C Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
11/23/2006	WO2006124887A1 Iminothiazolidinone derivatives as sfrp-1 antagonists
11/23/2006	WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/23/2006	WO2006123726A1 Pharmaceutical composition
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006123699A1 Inducer of differentiation of stem cell into osteoblast
11/23/2006	WO2006123639A1 Pyrimidine derivative
11/23/2006	WO2006123550A1 Prophylactic or therapeutic agent for inflammatory disease
11/23/2006	WO2006084757A3 Combination of ca/mg salt of valsartan with an antidiabetic agent
11/23/2006	WO2006033888A9 A process to treat avascular necrosis (avn) with osteoinductive materials
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264492 methyl [5(6)-(4-alanylaminophenylthio)-1H-benzimidazol-2yl]carbamate; for treating neovascularization, solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors

1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 820